Microglia and regulation of inflammation-mediated neurodegeneration: Prevention and treatment by phytochemicals and metabolic nutrients

International Journal of Green Pharmacy

Volumn 6, Issue 2, 2012, Pages 81-92

  Sundaram, Rajagopal Shanmuga ^a   Gowtham, Lakshminarayanan ^b  

^a Aditya Bangalore Institute for Pharmacy Education and Research   (India)

^b PSG COLLEGE OF PHARMACY   (India)

Author keywords

Astrocyte; flavonoids; free radical scavengers; microglia; neuroinflammation; phytochemicals

Indexed keywords

ACORUS CALAMUS EXTRACT; ANGELICA ROOT EXTRACT; ANTIOXIDANT; AZADIRACHTA INDICA EXTRACT; BACOPA MONNIERI EXTRACT; BUTEA FRONDOSA EXTRACT; CAMELLIA SINENSIS EXTRACT; CELASTRUS PAHICULATUS EXTRACT; CENTELLA ASIATICA EXTRACT; CLITORIA TERNATEA EXTRACT; CONVOLVULUS PLURICAULIS EXTRACT; ECLIPTA ALBA EXTRACT; EMBLICA OFFICINALE EXTRACT; FLAVONOID; GINKGO BILOBA EXTRACT; MUCUNA PRURIENS EXTRACT; NICOTINAMIDE; PANEX GINSENG EXTRACT; PLANT MEDICINAL PRODUCT; RASAYANA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIDA CORDIFOLIA EXTRACT; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN K GROUP; VITIS VINIFERA EXTRACT; WADELIA CALANDULACAE EXTRACT; WITHANIA SOMNIFERA EXTRACT;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTROCYTE; BRAIN EDEMA; BYSTANDER EFFECT; CELL ACTIVATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DNA DAMAGE; DNA STRAND BREAKAGE; HERBAL MEDICINE; INFLAMMATION; IRON CHELATION; LIPID PEROXIDATION; LUNG HILUS; MACROPHAGE; MEMBRANE FLUIDITY; MICROGLIA; MONOCYTE; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUTROPHIL; NUTRIENT; OCIMUM TENUIFLORUM; PHYTOCHEMISTRY; PREVENTION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TISSUE INJURY; TRAUMATIC BRAIN INJURY;

EID: 84870278928     PISSN: 09738258     EISSN: 19984103     Source Type: Journal    
DOI: 10.4103/0973-8258.102807     Document Type: Review

References (126)

1. Blaylock RL. Neurodegeneration and aging of the central nervous system: prevention and treatment by phytochemicals and metabolic nutrients. Integr Med 1998;1:117-33.
2. Singh RP, Sharad S, Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: Relevance of dietary antioxidants. J Indian Acad Clin Med 2004;5:218-25.
3. Standaert DG, Young AB. Treatment of central nervous degenerative disorders. In: Brunton LL, Lazo P, Parker KL, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New Delhi: McGrawYHill; 2006. p. 527-46.
4. Block ML, Hong JS. Microglia and inflammationYmediated neurodegeneration: multiple triggers with a common mechanism. Progr Neurobiol 2005:76;77-98.
5. Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-66.
6. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activationYmediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 2002;81:1285-97.
7. Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, et al. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J 2004;18:1618-20.
8. Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS. Microglias enhance betaYamyloid peptideYinduced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 2002;83:973-83.
9. Betarbet R, Sherer TB, MacKenzie G, GarciaYOsuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neueurosci 2000;3:1301-6.
10. Greenamyre JT, MacKenzie G, Peng TI, Stephans SE. Mitochondrial dysfunction in Parkinson's disease. Biochem Soc Symp 1999;66:85-97.
11. Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, et al. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 2005;26:133-40.
12. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al. Aggregated alphaYsynuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 2005;19:533-42.
13. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999;57:563-81.
14. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002;40:232-9.
15. SánchezYMoreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2003;35:163-8.
16. Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 1995;64Suppl 9:7-10.
17. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: Intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995;20:269-87.
18. Gremo F, Sogos V, Ennas MG, Meloni A, Persichini T, Colasanti M, et al. Features and functions of human microglia cells. Adv Exp Med Biol 1997;429:79-97.
19. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999;58:233-47.
20. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-18.
21. Minghetti L, Levi G. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 1998;54:99-125.
22. Gonzalez Y, Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999;22:219-40.
23. Araque A, Perea G. Glial modulation of synaptic transmission in culture. Glia 2004;47:241-8.
24. Vesce S, Bezzi P, Volterra A. The active role of astrocytes in synaptic transmission. Cell Mol Life Sci 1999;56:991-1000.
25. Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998;19:269-81.
26. Galea E, Feinstein DL, Reis DJ. Induction of calciumYindependent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci U S A 1992;89:10945-9.
27. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factorYalpha by microglia and astrocytes in culture. Brain Res 1989;491:394-7.
28. Simmons ML, Murphy S. Induction of nitric oxide synthase in glial cells. J Neurochem 1992;59:897-905.
29. Becher B, Prat A, Antel JP. BrainYimmune connection: Immunoregulatory properties of CNS resident cells. Glia 2000;29:293-304.
30. Nakamura Y. Regulating factors for microglial activation. Biol Pharm Bull 2002;25:945-53.
31. Ho LJ, Lai JH. Chinese herbs as immunomodulators and potential diseaseYmodifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab 2004;5:181-92.
32. Li FQ, Lu XZ, Liang XB, Zhou HF, Xue B, Liu XY, et al. Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammationYmediated damage through inhibition of microglial activation. J Neuroimmunol 2004;148:24-31.
33. Ward PA, Warren JS, Johnson KJ. Oxygen radicals, inflammation, and tissue injury. Free Radic Biol Med 1988;5:403-8.
34. Henson PM, Johnston RB Jr. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest 1987;79:669-74.
35. Rankin JA. Biological mediators of acute inflammation. AACN Clin Issues 2004;15:3-17.
36. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995;54:505-10.
37. Nakajima K, Kohsaka S. Microglia: Activation and their significance in the central nervous system. J Biochem 2001;130:169-75.
38. Liu B, Hong JS. Role of microglia in inflammationYmediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1-7.
39. Chavarria A, AlcocerYVarela J. Is damage in central nervous system due to inflammation? Autoimmun Rev 2004;3:251-60.
40. Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: Back to basics. Trends Pharmacol Sci 2003;24:13-7.
41. von Knethen A, Lotero A, Brune B. Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMPYinduced gene expression. Oncogene 1998;17:387-94.
42. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxideYmediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080-5.
43. Adler B, Adler H, Jungi TW, Peterhans E. InterferonYalpha primes macrophages for lipopolysaccharideYinduced apoptosis. Biochem Biophys Res Commun 1995;215:921-7.
44. Liu B, Wang K, Gao HM, Mandavilli B, Wang JY, Hong JS. Molecular consequences of activated microglia in the brain: Overactivation induces apoptosis. J Neurochem 2001;77:182-9.
45. Lee P, Lee J, Kim S, Lee MS, Yagita H, Kim SY, et al. NO as an autocrine mediator in the apoptosis of activated microglial cells: Correlation between activation and apoptosis of microglial cells. Brain Res 2001;892:380-5.
46. Suk K, Lee J, Hur J, Kim YS, Lee M, Cha S, et al. ActivationYinduced cell death of rat astrocytes. Brain Res 2001;900:342-7.
47. Donjerkovic D, Scott DW. ActivationYinduced cell death in B lymphocytes. Cell Res 2000;10:179-92.
48. Crispe IN. Death and destruction of activated T lymphocytes. Immunol Res 1999;19:143-57.
49. Kingham PJ, Cuzner ML, Pocock JM. Apoptotic pathways mobilized in microglia and neurons as a consequence of chromogranin AYinduced microglial activation. J Neurochem 1999;73:538-47.
50. Kingham PJ, Pocock JM. Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release. J Neurochem 2000;74:1452-62.
51. Yang MS, Park EJ, Sohn S, Kwon HJ, Shin WH, Pyo HK, et al. InterleukinY13 and Y14 induce death of activated microglia. Glia 2002;38:273-80.
52. Takano K, Nakamura Y, Yoneda Y. Microglialcell death induced by a low concentration of polyamines. Neurosci 2003;120:961-67.
53. Lee J, Hur J, Lee P, Kim JY, Cho N, Kim SY, et al. Dual role of inflammatory stimuli in activationYinduced cell death of mouse microglial cells: initiation of two separate apoptotic pathways via induction of interferon regulatory factorY1 and caspaseY11. J Biol Chem 2001;276:32956-65.
54. Lee H, Cha S, Lee MS, Cho GJ, Choi WS, Suk K. Role of antiproliferative B cell translocation geneY1 as an apoptotic sensitizer in activation induced cell death of brain microglia. J Immunol 2003;171:5802-11.
55. Suk K, Kim SY, Kim H. Essential role of caspaseY11 in activationinduced cell death of rat astrocytes. J Neurochem 2002;80:230-8.
56. Drache B, Diehl GE, Beyreuther K, Perlmutter LS, Konig G. bclYxlYspecific antibody labels activated microglia associated with Alzheimer's disease and other pathological states. J Neurosci Res 1997;47:98-108.
57. Migheli A, Cavalla P, Piva R, Giordana MT, Schiffer D. bclY2 protein expression in aged brain and neurodegenerative diseases. Neuroreport 1994;5:1906-8.
58. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004;77:1-8.
59. Giulian D. Amoeboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 1987;18:155-71, 132-3.
60. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 1995;27:119-37.
61. Nagata K, Takei N, Nakajima K, Saito H, Kohsaka S. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J Neurosci Res 1993;34:357-63.
62. McGeer PL, McGeer EG. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995;21:195-218.
63. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993;7:84-92.
64. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002;40:140-55.
65. RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker Inc; 1998.
66. Hirano T, Oka K, Akibam M. Antiproliferative effect of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZRY75-1. Res Comm Chem Pathol Pharmacol 1989;64:69-79.
67. Arnold A, Carughi M, Farina G, Merlini L, Parrino MG. Synthetic analogs of phytoalexins, synthesis and antifungal activity of potential free radical scavengers. J Agric Food Chem 1989;37:508-12.
68. Wacker A, Hilbig W. Virus inhibition by Echinacea purpurea. Planta Med 1978;33:89-102.
69. Stimpel M, Proksch A, Wagner H, LohmannYMatthes ML. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpura. Infect Immun 1984;46:845-9.
70. Hertog MGL, Feskens EJ, Hollaman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993;342:1007-11.
71. Krieglstein J, Beck T, Seibert A. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 1986;39:2327-34.
72. De Smet PA. Herbal remedies. N Engl J Med 2002;347:2046-56.
73. Harvey AL. Medicines from nature: are natural products still relevant to drug discovery? Trends Pharmacol Sci 1999;20:196-8
74. Ashok AB. The status and scope of Indian medicinal plants acting on central nervous system. Ind J Pharmacol 1997;29:S340-3.
75. Carlini EA. Plants and the central nervous system. Pharmacol Biochem Behav 2003;75:501-12.
76. Howes MJ, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 2003;75:513-27.
77. Shanmuga Sundaram R, Ramanathan M, Gowtham L, Kumar JP, Bihari CG, Manikandan P, et al. Investigation of standardized ethanol extract of Ocimum sanctum Linn. (Holy Basil) leaves for its in vitro antioxidant potential and phenolic composition. Asian J Chem 2012;24:1819-24.
78. Gertz HJ, Kiefer M. Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr Pharm Des 2004;10:261-4.
79. Jovanovic SV, Steenken S, Simic MG, Hara Y. Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoid radicals. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker, Inc; 1998. p. 137-61.
80. Morel I, Cillard P, Cillard J. FlavonoidYmetal interactions in biological systems. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker Inc; 1998. p. 163-77.
81. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: importance of their interactions with biomembranes. Free Radic Biol Med 1995;19:481-6.
82. Ratty AK, Das NP. Effects of flavonoids on nonenzymatic lipid peroxidation: structureYactivity relationship. Biochem Med Metab Biol 1988;39:69-79.
83. Kuttan R, Donnely PV, DiFerrante N. Collagen treated with (1)Ycatechin becomes resistant to the action of mammalian collagenase. Expermentia 1981;37:221-5.
84. Robert AM, Godeau G, Moati F, Miskulin M. Action of anthrocyanosides of vaccinium myrtillis on the permeability of the bloodYbrain barrier. J Med 1977;8:321-32.
85. Tzeng SH, Ko WC, Ko FN, Teng CM. Inhibition of platelet aggregation by some flavonoids. Thromb Res 1991;64:91-100.
86. Kim HP, Mani I, Iversen L, Ziboh VA. Effects of naturally occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipooxygenase from guinea pigs. Prostaglandins Leukot Essent Fatty Acids 1998;58:17-24.
87. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann Neurol 1992;32:804-12.
88. Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: Relevance to cyto (neuro) toxic events and neurologic disorders: an overview. Neurotox Res 2000;1:197-233.
89. Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 2003;60:1779-92.
90. Kim YO, Leem K, Park J, Lee P, Ahn DK, Lee BC, et al. Cytoprotective effect of Scutellaria baicalensis in CA1 hippocampal neurons of rats after global cerebral ischaemia. J Ethnopharmacol 2001;77:183-8.
91. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996;712:349-52.
92. Rahman K. Garlic and aging: new insights into an old remedy. Ageing Res Rev 2003;2:39-56.
93. Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation 1997;21:347-56.
94. Pietta P. Flavonoids in medicinal plants. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker Inc; 1998. p. 61-110.
95. Rohdewald P. Pycnogenol. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker Inc; 1998. p. 405-19.
96. BenYAri Y, Aniksztejn L, Bregestovski P. Protein kinase C modulation for NMDA currents: an important link for LTP induction. Trends Neurosci 1992;15:333-8.
97. Duthie SJ, Collins AR, Duthie GG, Dobsoin VL. Quercetin and myricetin protect against hydrogen peroxideYinduced DNA damage (strand breaks and oxidized pyrimidines) in human lymphocytes. Mutat Res 1997;393:223-31.
98. Griffiths LA. Mammalian metabolism of flavonoids. In: Harborne JB, Mabry IJ, editors. The flavonoids: advances in research. London: Chapman and Hall; 1982. p. 681.
99. Li CL, Werner P, Cohen G. Lipid peroxidation in brain: interaction of LYDOPA/dopamine with ascorbate and iron. Neurodegeneration 1995;4:147-53.
100. Afanas'ev BI, Ostrachovitch AE, Abramova EN, Korkina GL. Different antioxidant activities of bioflavonoid rutin in normal and ironYoverloading rats. Biochem Pharmacol 1995;50:627-35.
101. Dexter DT, Carayon A, JavoyYAgid F, Agid Y, Wells FR, Daniel SE, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglion. Brain 1991;114:1953-75.
102. Kasarskis EJ, Tandon L, Lovell MA, Ehmann WD. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci 1995;130:203-8.
103. Cos P, Ying L, Calomme M, Hu JP, Cimanga K, Van Poel B, et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998;61:71-6.
104. Van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Comm 1995;214:755-9.
105. Schubert D, Kimura H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci U S A 1992;89:8264-8.
106. Hertog MGL, Katan MB. Quercetin in foods, cardiovascular disease and cancer. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker, Inc; 1998. p. 447-67.
107. Tero J, Piskula MK. Flavanoids as inhibitors of lipid peroxidation in membranes. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker, Inc; 1998. p. 277-93.
108. Blanc EM, Kelly JF, Mark RJ, Waeg G, Mattson MP. 4-Hydroxynonenal, an aldehyde product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible actions on G alpha (q/II). J Neurochem 1997;69:570-80.
109. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998;22:149-60.
110. Chromé J, Paul T, Pudel V, Bleyl H, Heseker H, Hppe R, et al. Effect of suboptimal vitamin status on behavior. In: Somogyi JC, Hotzel D, editors. Nutrition and neurobiology. New York: Kaeger; 1986. p. 94-103.
111. Sahu SC, Gray GC. Interactions of flavonoids, trace metals and oxygen: nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Lett 1993;70:73-9.
112. Sahu SG, Gray GC. KaempferolYinduced nuclear DNA damage and lipid peroxidation. Cancer Lett 1994;85:159-64.
113. Smith S, Halliwell B, Aruma OI. Protection by albumin against prooxidant actions of phenolic dietary components. Food Chem Toxicol 1992;30:483-9.
114. Packer L, Saliou C, DroyYLefaix MT, Christen Y. Ginkgo biloba extract Egb 761: biological actions, antioxidant activity, and regulation of nitric oxide synthetase. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker, Inc; 1998. p. 303-41.
115. Yoneda T, Hiramatsu M, Sakamoto M, Togasaki K, Komatsu M, Yamaguchi K. Antioxidant effects of beta catechins. Biochem Mol Biol Int 1995;35:995-1008.
116. Rohdewald P. Pycnogenol. In: RiceYEvans CA, Packer L, editors. Flavonoids in health and disease. New York: Marcel Dekker, Inc; 1998. p. 405-19.
117. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloidal betaYprotein toxicity. Cell 1994;77:817-27.
118. Schubert D, Kimurah H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci U S A 1992;89:8264-8.
119. Scheibel AB, Duong T. On the possible relationship of cortical microvascular pathology to bloodYbrain barrier changes in Alzheimer's disease. Neurobiol Aging 1988;9:41-2.
120. Grotemeyer KH. The plateletYreactivity testY a useful byYproduct of blood sampling procedure. Thromb Res 1991;61:423-31.
121. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed cainine coronary arteries. Circulation 1995;91:1182-8.
122. Shanmuga Sundaram R, Ramanathan M, Rajesh R, Satheesh B, Saravanan D. LCYMS quantification of rosmarinic acid and ursolic acid in the Ocimum sanctum Linn. leaf extract (Holy basil, Tulsi). J Liq Chromatogr Relat Technol 2012;35:634-50.
123. Shanmuga Sundaram R, Gowtham L, Manikandan P, Venugopal V, Kamalakannan D. The role of reactive microglia in neurodegenerative disease: Multiple triggers with a common mechanism. Int J Recent Adv Pharm Res 2012;2:29-40.
124. Shanmuga Sundaram R, Gowtham L, Bhabani SN. The role of excitatory neurotransmitter glutamate in brain physiology and pathology. Asian J Pharm Clin Res 2012;5:1-7.
125. Shanmuga Sundaram R, Gowtham L, Manikandan P, Venugopal V, Kamalakannan D. Neuronal apoptosis and necrosis: role of excitotoxins, calcium, oxidative stress. Int J Res Pharm Biomed Sci 2012;3:567-75.
126. Lolic MM, Fiskum G, Rosenthal RE. Neuroprotective effects of acetylYLYcarnitine after stroke in rats. Ann Emerg Med 1997; 29:758-65.